Evidence map›Paper›PMID 31894341›Full record

ArticleOncology reports2020

Cryopreserved biopsy tissues of rectal cancer liver metastasis for assessment of anticancer drug response in vitro and in vivo.

Yuan Zhang, Wei-Jian Huang, Qiu-Rui Yang, Hong-Dan Zhang, Xue-Jing Zhu, Min Zeng, Xu Zhou, Zhen-Yu Wang, Wei-Jian Li, Hong-Shu Jing and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Oncology reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Enhanced synthesis of antibody-functionalized gold nanoparticles for multiplexed exosome detection via mass signal amplification in LDI-TOF MS.Analytical sciences : the international journal of the Japan Society for Analytical Chemistry · 2024
    Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Yuan Zhang *Department of Tumor Interventional Oncology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200127, P.R. China.
Wei-Jian Huang *International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Institute, The Second Military Medical University, Shanghai 200438, P.R. China.
Qiu-Rui YangShanghai Celliver Biotechnology Co., Shanghai 201203, P.R. China.
Hong-Dan ZhangShanghai Celliver Biotechnology Co., Shanghai 201203, P.R. China.
Xue-Jing ZhuShanghai Celliver Biotechnology Co., Shanghai 201203, P.R. China.
Min ZengInternational Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Institute, The Second Military Medical University, Shanghai 200438, P.R. China.
Xu ZhouInternational Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Institute, The Second Military Medical University, Shanghai 200438, P.R. China.
Zhen-Yu WangDepartment of Tumor Interventional Oncology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200127, P.R. China.
Wei-Jian LiDepartment of Tumor Interventional Oncology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200127, P.R. China.
Hong-Shu JingDepartment of Tumor Interventional Oncology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200127, P.R. China.
Xue-Bin ZhangDepartment of Tumor Interventional Oncology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200127, P.R. China.
Yao-Ping ShiDepartment of Tumor Interventional Oncology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200127, P.R. China.
Hao HuDepartment of Tumor Interventional Oncology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200127, P.R. China.
He-Xin YanDepartment of Tumor Interventional Oncology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200127, P.R. China.
Zong-Hai LiState Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200032, P.R. China.
Bo ZhaiDepartment of Tumor Interventional Oncology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200127, P.R. China.
Renji Hospital · CNSecond Military Medical University · CNEastern Hepatobiliary Surgery Hospital · CNShanghai Cancer Institute · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Living tumors are of great scientific value for clinical medicine and basic research, especially for drug testing. An increasing number of drug tests fail due to the use of imperfect models. The aim of the present study was to develop a novel method combining vitrification‑based cryopreservation of tumor biopsies and precision‑cut slice cultivation for the assessment of anticancer drug responses. Biological characteristics of rectal cancer liver metastasis biopsies could be retained by vitrification‑based cryopreservation. The patient‑derived xenograft models were successfully established using both fresh and warmed biopsy tissues. Precision‑cut slicing provided a similar three‑dimensional architecture and heterogeneity to the original tumor. The positive drug responses in the xenograft model were consistent with those in precision‑cut slice cultures in vitro. The present study demonstrated that live tumor biopsies could be preserved using vitrification‑based cryopreservation. The warmed tissues developed xenograft tumors, which were also useful for either in vivo or in vitro anticancer drug testing. Precision‑cut slices derived from the warmed tissues provided an efficient tool to assess anticancer drug response in vitro.

Indexed as

AnimalsAntineoplastic AgentsBiomarkers, TumorBiopsyCryopreservationFemaleHumansLiver NeoplasmsMaleMiceMiddle AgedRectal NeoplasmsTissue Culture TechniquesTreatment OutcomeVitrificationXenograft Model Antitumor AssaysAntineoplastic AgentsBiomarkers, TumorbiopsyOXAprecision-cut sliceRLMvitrification-based cryopreservation

Identifiers

PMID31894341
PMCPMC6967191
OpenAlexW2997661403

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.